Concepts (337)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hip Fractures | 36 | 2024 | 988 | 6.850 |
Why?
|
| Norway | 68 | 2023 | 499 | 4.450 |
Why?
|
| Emigrants and Immigrants | 12 | 2018 | 543 | 2.990 |
Why?
|
| Vitamin D | 20 | 2020 | 3303 | 2.180 |
Why?
|
| Osteoporosis | 13 | 2023 | 1606 | 1.560 |
Why?
|
| Nutritional Status | 9 | 2020 | 1615 | 1.310 |
Why?
|
| Iodine | 2 | 2020 | 288 | 1.110 |
Why?
|
| Vitamin D Deficiency | 9 | 2020 | 1388 | 1.090 |
Why?
|
| Dietary Supplements | 11 | 2020 | 3415 | 0.980 |
Why?
|
| Fractures, Bone | 10 | 2019 | 2046 | 0.880 |
Why?
|
| Body Mass Index | 22 | 2021 | 12953 | 0.870 |
Why?
|
| Cardiovascular Diseases | 14 | 2023 | 15500 | 0.800 |
Why?
|
| Emigration and Immigration | 3 | 2018 | 397 | 0.710 |
Why?
|
| Potassium, Dietary | 2 | 2019 | 103 | 0.690 |
Why?
|
| Arthroplasty, Replacement, Hip | 6 | 2023 | 1413 | 0.660 |
Why?
|
| Vitamin B 12 | 3 | 2019 | 524 | 0.610 |
Why?
|
| Risk Factors | 52 | 2023 | 74206 | 0.600 |
Why?
|
| Vitamin B 6 | 1 | 2019 | 234 | 0.590 |
Why?
|
| Vitamin A | 3 | 2015 | 613 | 0.590 |
Why?
|
| Deficiency Diseases | 1 | 2018 | 74 | 0.590 |
Why?
|
| Prediabetic State | 2 | 2020 | 545 | 0.580 |
Why?
|
| Rickets | 1 | 2017 | 70 | 0.550 |
Why?
|
| Bone Density Conservation Agents | 4 | 2023 | 795 | 0.540 |
Why?
|
| Bone Density | 11 | 2020 | 3551 | 0.540 |
Why?
|
| Sri Lanka | 6 | 2013 | 93 | 0.530 |
Why?
|
| Mothers | 3 | 2013 | 2198 | 0.530 |
Why?
|
| Elder Nutritional Physiological Phenomena | 1 | 2015 | 7 | 0.520 |
Why?
|
| Sodium, Dietary | 1 | 2019 | 425 | 0.510 |
Why?
|
| Obesity, Abdominal | 2 | 2016 | 374 | 0.500 |
Why?
|
| Nutrition Policy | 4 | 2020 | 471 | 0.500 |
Why?
|
| Forearm Injuries | 2 | 2015 | 68 | 0.490 |
Why?
|
| Vitamin B Complex | 1 | 2017 | 299 | 0.490 |
Why?
|
| Urban Health | 1 | 2017 | 532 | 0.480 |
Why?
|
| Somalia | 7 | 2019 | 78 | 0.480 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2017 | 352 | 0.470 |
Why?
|
| Male | 95 | 2023 | 360804 | 0.470 |
Why?
|
| Cohort Studies | 26 | 2024 | 41487 | 0.450 |
Why?
|
| Sex Factors | 12 | 2018 | 10552 | 0.450 |
Why?
|
| Female | 95 | 2024 | 392644 | 0.450 |
Why?
|
| Overweight | 6 | 2019 | 2417 | 0.430 |
Why?
|
| Marital Status | 1 | 2014 | 426 | 0.410 |
Why?
|
| Spinal Fractures | 1 | 2019 | 705 | 0.410 |
Why?
|
| Middle Aged | 73 | 2024 | 220895 | 0.410 |
Why?
|
| Seasons | 3 | 2014 | 1520 | 0.400 |
Why?
|
| Proportional Hazards Models | 14 | 2022 | 12463 | 0.400 |
Why?
|
| Calcium, Dietary | 4 | 2015 | 529 | 0.400 |
Why?
|
| Urban Population | 5 | 2019 | 2036 | 0.390 |
Why?
|
| Osteoarthritis, Hip | 3 | 2023 | 409 | 0.390 |
Why?
|
| Anthropometry | 2 | 2013 | 1349 | 0.390 |
Why?
|
| Cross-Sectional Studies | 24 | 2021 | 26125 | 0.390 |
Why?
|
| Pakistan | 7 | 2011 | 292 | 0.380 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2013 | 540 | 0.380 |
Why?
|
| Vitamins | 4 | 2015 | 1635 | 0.380 |
Why?
|
| Humans | 117 | 2024 | 761504 | 0.370 |
Why?
|
| Osteoporotic Fractures | 1 | 2015 | 411 | 0.360 |
Why?
|
| Acculturation | 1 | 2012 | 178 | 0.360 |
Why?
|
| Body Weight | 5 | 2008 | 4618 | 0.360 |
Why?
|
| Aged | 53 | 2022 | 169289 | 0.360 |
Why?
|
| Age Factors | 12 | 2018 | 18395 | 0.360 |
Why?
|
| Diet, Fat-Restricted | 1 | 2013 | 329 | 0.360 |
Why?
|
| Adult | 58 | 2021 | 221177 | 0.340 |
Why?
|
| Calcifediol | 3 | 2017 | 161 | 0.340 |
Why?
|
| Waist Circumference | 4 | 2019 | 935 | 0.330 |
Why?
|
| Incidence | 13 | 2022 | 21353 | 0.330 |
Why?
|
| Muscle Strength | 1 | 2013 | 624 | 0.330 |
Why?
|
| Nutritional Sciences | 1 | 2011 | 144 | 0.330 |
Why?
|
| Health Status Disparities | 3 | 2016 | 1852 | 0.320 |
Why?
|
| Diet | 5 | 2024 | 8075 | 0.310 |
Why?
|
| Rural Population | 4 | 2017 | 2285 | 0.310 |
Why?
|
| Brazil | 3 | 2021 | 1230 | 0.310 |
Why?
|
| Infant Welfare | 1 | 2008 | 80 | 0.310 |
Why?
|
| Turkey | 4 | 2011 | 254 | 0.300 |
Why?
|
| Urinalysis | 3 | 2019 | 368 | 0.300 |
Why?
|
| Absorptiometry, Photon | 4 | 2008 | 1738 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2021 | 12148 | 0.300 |
Why?
|
| Prospective Studies | 22 | 2022 | 54425 | 0.290 |
Why?
|
| Asia | 5 | 2017 | 619 | 0.290 |
Why?
|
| Weight Gain | 4 | 2019 | 2348 | 0.290 |
Why?
|
| Hip | 2 | 2008 | 255 | 0.280 |
Why?
|
| Population Surveillance | 6 | 2018 | 2598 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3415 | 0.270 |
Why?
|
| Prevalence | 14 | 2020 | 15732 | 0.270 |
Why?
|
| Risk Assessment | 9 | 2018 | 23995 | 0.270 |
Why?
|
| Radius Fractures | 2 | 2011 | 515 | 0.260 |
Why?
|
| Sex Distribution | 4 | 2020 | 2281 | 0.260 |
Why?
|
| Follow-Up Studies | 15 | 2020 | 39106 | 0.250 |
Why?
|
| Prostatic Neoplasms | 4 | 2018 | 11118 | 0.250 |
Why?
|
| Obesity | 10 | 2021 | 12947 | 0.250 |
Why?
|
| Dietary Fats | 1 | 2013 | 1995 | 0.240 |
Why?
|
| Fatty Acids | 1 | 2013 | 1808 | 0.240 |
Why?
|
| Weight Loss | 3 | 2008 | 2684 | 0.240 |
Why?
|
| Life Style | 4 | 2013 | 3917 | 0.240 |
Why?
|
| Hyperparathyroidism, Secondary | 2 | 2006 | 125 | 0.240 |
Why?
|
| Registries | 8 | 2023 | 8224 | 0.230 |
Why?
|
| Body Composition | 1 | 2013 | 2426 | 0.230 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 1112 | 0.230 |
Why?
|
| Cholesterol, HDL | 2 | 2009 | 1814 | 0.220 |
Why?
|
| Forearm | 4 | 2021 | 427 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2017 | 10209 | 0.210 |
Why?
|
| Exercise | 6 | 2022 | 5890 | 0.210 |
Why?
|
| Young Adult | 19 | 2021 | 59243 | 0.210 |
Why?
|
| Smoking | 9 | 2019 | 9053 | 0.210 |
Why?
|
| Hormone Replacement Therapy | 1 | 2008 | 751 | 0.210 |
Why?
|
| Breast Feeding | 2 | 2008 | 1359 | 0.200 |
Why?
|
| Comorbidity | 6 | 2023 | 10508 | 0.200 |
Why?
|
| Alcohol Drinking | 5 | 2019 | 4028 | 0.200 |
Why?
|
| Femur | 1 | 2007 | 1307 | 0.190 |
Why?
|
| Fish Products | 1 | 2020 | 30 | 0.180 |
Why?
|
| Cod Liver Oil | 2 | 2015 | 9 | 0.180 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2004 | 396 | 0.180 |
Why?
|
| Risk | 5 | 2015 | 9610 | 0.180 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 2319 | 0.180 |
Why?
|
| Postmenopause | 4 | 2024 | 2513 | 0.180 |
Why?
|
| Socioeconomic Factors | 5 | 2015 | 7827 | 0.180 |
Why?
|
| Chronic Disease | 2 | 2015 | 9318 | 0.170 |
Why?
|
| Parents | 1 | 2014 | 3563 | 0.170 |
Why?
|
| Homocysteine | 2 | 2017 | 638 | 0.170 |
Why?
|
| Educational Status | 5 | 2015 | 2522 | 0.170 |
Why?
|
| Eggs | 1 | 2020 | 182 | 0.160 |
Why?
|
| Diet Surveys | 2 | 2020 | 1162 | 0.160 |
Why?
|
| Vietnam | 3 | 2011 | 409 | 0.160 |
Why?
|
| Pelvic Bones | 1 | 2021 | 270 | 0.160 |
Why?
|
| Case-Control Studies | 6 | 2018 | 22176 | 0.160 |
Why?
|
| Natriuresis | 1 | 2018 | 105 | 0.160 |
Why?
|
| Cold Temperature | 1 | 2022 | 785 | 0.150 |
Why?
|
| Folic Acid | 3 | 2017 | 1323 | 0.150 |
Why?
|
| Nutrition Assessment | 2 | 2019 | 728 | 0.150 |
Why?
|
| Aged, 80 and over | 14 | 2019 | 58976 | 0.150 |
Why?
|
| Immunity | 2 | 2023 | 996 | 0.150 |
Why?
|
| Nutritional Requirements | 3 | 2019 | 276 | 0.150 |
Why?
|
| Alcoholic Beverages | 1 | 2019 | 264 | 0.150 |
Why?
|
| Linear Models | 5 | 2016 | 5871 | 0.140 |
Why?
|
| Cholecalciferol | 2 | 2016 | 553 | 0.140 |
Why?
|
| Seafood | 1 | 2020 | 393 | 0.140 |
Why?
|
| Dairy Products | 1 | 2020 | 490 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 11460 | 0.140 |
Why?
|
| Hypertension | 4 | 2017 | 8540 | 0.140 |
Why?
|
| Blood Banks | 1 | 2017 | 108 | 0.140 |
Why?
|
| Feeding Behavior | 4 | 2018 | 3188 | 0.140 |
Why?
|
| Radius | 2 | 2011 | 441 | 0.130 |
Why?
|
| Yugoslavia | 1 | 2015 | 23 | 0.130 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2018 | 293 | 0.130 |
Why?
|
| Statistics, Nonparametric | 2 | 2020 | 2850 | 0.130 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2015 | 40 | 0.130 |
Why?
|
| Databases, Factual | 2 | 2015 | 7967 | 0.130 |
Why?
|
| Temperature | 1 | 2022 | 2226 | 0.130 |
Why?
|
| Double-Blind Method | 4 | 2019 | 12341 | 0.130 |
Why?
|
| Self Report | 3 | 2022 | 3724 | 0.120 |
Why?
|
| alpha-Tocopherol | 1 | 2015 | 126 | 0.120 |
Why?
|
| Potassium | 1 | 2019 | 1311 | 0.120 |
Why?
|
| Infant | 6 | 2020 | 36192 | 0.120 |
Why?
|
| Iran | 2 | 2009 | 737 | 0.120 |
Why?
|
| Job Description | 1 | 2014 | 59 | 0.120 |
Why?
|
| Health Plan Implementation | 1 | 2017 | 337 | 0.120 |
Why?
|
| Diabetes Mellitus | 5 | 2019 | 5840 | 0.120 |
Why?
|
| Osteoarthritis | 1 | 2002 | 1063 | 0.110 |
Why?
|
| Sodium | 1 | 2019 | 1588 | 0.110 |
Why?
|
| Vegetables | 2 | 2024 | 1195 | 0.110 |
Why?
|
| Iron | 2 | 2016 | 1793 | 0.110 |
Why?
|
| Ergocalciferols | 1 | 2014 | 110 | 0.110 |
Why?
|
| Stroke | 1 | 2015 | 9757 | 0.110 |
Why?
|
| Aluminum | 1 | 2013 | 152 | 0.110 |
Why?
|
| Myanmar | 3 | 2017 | 44 | 0.110 |
Why?
|
| Africa South of the Sahara | 1 | 2015 | 744 | 0.100 |
Why?
|
| Body Fat Distribution | 1 | 2014 | 245 | 0.100 |
Why?
|
| Cadmium | 1 | 2013 | 214 | 0.100 |
Why?
|
| Carotenoids | 1 | 2015 | 621 | 0.100 |
Why?
|
| Waist-Hip Ratio | 1 | 2013 | 518 | 0.100 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2016 | 369 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2017 | 1173 | 0.100 |
Why?
|
| Cholesterol | 4 | 2019 | 2904 | 0.100 |
Why?
|
| Language | 2 | 2012 | 1540 | 0.100 |
Why?
|
| Child Health Services | 1 | 2017 | 646 | 0.100 |
Why?
|
| Motor Activity | 2 | 2014 | 2715 | 0.100 |
Why?
|
| Calcium | 4 | 2012 | 5722 | 0.100 |
Why?
|
| Body Weights and Measures | 1 | 2012 | 208 | 0.100 |
Why?
|
| Physical Fitness | 2 | 2009 | 743 | 0.090 |
Why?
|
| Maternal-Child Health Centers | 1 | 2011 | 42 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2018 | 675 | 0.090 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 368 | 0.090 |
Why?
|
| Drug Utilization | 2 | 2014 | 1188 | 0.090 |
Why?
|
| Ulna | 1 | 2011 | 134 | 0.090 |
Why?
|
| Adolescent | 12 | 2021 | 88319 | 0.090 |
Why?
|
| Nutrition Surveys | 2 | 2015 | 1733 | 0.090 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 1336 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 14605 | 0.090 |
Why?
|
| Ulna Fractures | 1 | 2011 | 126 | 0.090 |
Why?
|
| Endpoint Determination | 1 | 2012 | 590 | 0.080 |
Why?
|
| Magnesium | 1 | 2013 | 804 | 0.080 |
Why?
|
| Calibration | 2 | 2013 | 818 | 0.080 |
Why?
|
| Placebos | 1 | 2013 | 1667 | 0.080 |
Why?
|
| Ferritins | 2 | 2016 | 598 | 0.080 |
Why?
|
| Blood Glucose | 3 | 2019 | 6391 | 0.080 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2011 | 224 | 0.080 |
Why?
|
| Minority Groups | 2 | 2013 | 1203 | 0.080 |
Why?
|
| Cross-Cultural Comparison | 1 | 2012 | 635 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 1469 | 0.080 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 1670 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 803 | 0.070 |
Why?
|
| Lead | 1 | 2013 | 879 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 3763 | 0.070 |
Why?
|
| Mass Screening | 2 | 2017 | 5428 | 0.070 |
Why?
|
| Fruit | 1 | 2013 | 1160 | 0.070 |
Why?
|
| Time Factors | 6 | 2018 | 39967 | 0.070 |
Why?
|
| Child | 8 | 2021 | 80153 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4853 | 0.070 |
Why?
|
| Drug Costs | 1 | 2015 | 1183 | 0.070 |
Why?
|
| Health Status | 2 | 2011 | 4077 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 3220 | 0.070 |
Why?
|
| Headache | 1 | 2014 | 1256 | 0.070 |
Why?
|
| Hemoglobins | 2 | 2016 | 1525 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2014 | 6343 | 0.070 |
Why?
|
| Growth | 1 | 2007 | 365 | 0.060 |
Why?
|
| Logistic Models | 4 | 2015 | 13255 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3963 | 0.060 |
Why?
|
| Body Height | 3 | 2008 | 1570 | 0.060 |
Why?
|
| Reference Values | 2 | 2015 | 4920 | 0.060 |
Why?
|
| Cause of Death | 1 | 2016 | 3683 | 0.060 |
Why?
|
| Health Surveys | 2 | 2013 | 4061 | 0.060 |
Why?
|
| Health Behavior | 1 | 2016 | 2643 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2015 | 2690 | 0.060 |
Why?
|
| Diphosphonates | 2 | 2023 | 636 | 0.060 |
Why?
|
| Acute Disease | 1 | 2015 | 7237 | 0.060 |
Why?
|
| Dietary Services | 1 | 2004 | 17 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2020 | 42230 | 0.060 |
Why?
|
| Survival Rate | 2 | 2016 | 12725 | 0.060 |
Why?
|
| Canada | 1 | 2010 | 2122 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 2691 | 0.060 |
Why?
|
| Age Distribution | 1 | 2010 | 2880 | 0.060 |
Why?
|
| Reference Standards | 1 | 2007 | 1003 | 0.060 |
Why?
|
| Osteoarthritis, Knee | 1 | 2014 | 1234 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2009 | 970 | 0.060 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2014 | 1393 | 0.050 |
Why?
|
| Middle East | 2 | 2016 | 231 | 0.050 |
Why?
|
| Fish Oils | 1 | 2007 | 483 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14666 | 0.050 |
Why?
|
| Recurrence | 2 | 2012 | 8465 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 4016 | 0.050 |
Why?
|
| Bone Resorption | 1 | 2006 | 723 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15842 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 488 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2020 | 26198 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2002 | 393 | 0.050 |
Why?
|
| Work | 1 | 2002 | 195 | 0.050 |
Why?
|
| Mortality | 1 | 2012 | 2901 | 0.050 |
Why?
|
| Hip Prosthesis | 1 | 2007 | 921 | 0.050 |
Why?
|
| Public Health | 1 | 2013 | 2669 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 691 | 0.040 |
Why?
|
| Spouses | 1 | 2002 | 283 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2007 | 2115 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2006 | 1273 | 0.040 |
Why?
|
| Blood Pressure | 4 | 2019 | 8481 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29625 | 0.040 |
Why?
|
| Physical Exertion | 1 | 2002 | 667 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2007 | 2526 | 0.040 |
Why?
|
| Food, Fortified | 1 | 2020 | 190 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 1055 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2009 | 15266 | 0.040 |
Why?
|
| Secondary Prevention | 2 | 2015 | 1475 | 0.040 |
Why?
|
| Coronary Disease | 2 | 2002 | 5914 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 20098 | 0.040 |
Why?
|
| Parathyroid Hormone | 1 | 2004 | 1803 | 0.040 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 1386 | 0.040 |
Why?
|
| New Zealand | 1 | 2017 | 358 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7390 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2010 | 3443 | 0.030 |
Why?
|
| Reoperation | 1 | 2007 | 4303 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2017 | 238 | 0.030 |
Why?
|
| Transferrin | 1 | 2016 | 283 | 0.030 |
Why?
|
| Aging | 1 | 2013 | 8708 | 0.030 |
Why?
|
| Finland | 1 | 2015 | 607 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2018 | 9646 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2021 | 1242 | 0.030 |
Why?
|
| United States | 2 | 2019 | 72334 | 0.030 |
Why?
|
| Trace Elements | 1 | 2015 | 195 | 0.030 |
Why?
|
| Teriparatide | 1 | 2015 | 227 | 0.030 |
Why?
|
| Denmark | 1 | 2015 | 771 | 0.030 |
Why?
|
| Neoplasms | 2 | 2017 | 22170 | 0.030 |
Why?
|
| Pregnancy | 2 | 2020 | 29874 | 0.030 |
Why?
|
| Urbanization | 1 | 2013 | 100 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 10766 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 983 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 413 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 683 | 0.020 |
Why?
|
| Heart Rate | 1 | 2022 | 4195 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3422 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 1380 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 4431 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2017 | 868 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1440 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2707 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1188 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 168459 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 609 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2009 | 248 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10090 | 0.020 |
Why?
|
| Occupational Health | 1 | 2014 | 806 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2007 | 61 | 0.020 |
Why?
|
| Prostate | 1 | 2015 | 1770 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3688 | 0.020 |
Why?
|
| Tablets | 1 | 2007 | 148 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2006 | 139 | 0.020 |
Why?
|
| Capsules | 1 | 2007 | 191 | 0.020 |
Why?
|
| Biological Availability | 1 | 2007 | 390 | 0.020 |
Why?
|
| Social Class | 1 | 2015 | 2004 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2006 | 274 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2015 | 2161 | 0.020 |
Why?
|
| Asthma | 1 | 2004 | 6234 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2004 | 6228 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 3826 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2014 | 3550 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 864 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.010 |
Why?
|
| Eicosanoic Acids | 1 | 2002 | 15 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 64680 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6310 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2006 | 1687 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2002 | 615 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12059 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11121 | 0.010 |
Why?
|
| China | 1 | 2006 | 2369 | 0.010 |
Why?
|
| Fasting | 1 | 2006 | 1603 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2009 | 2093 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6240 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 4021 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2927 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2013 | 4330 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2018 | 80636 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 2477 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2004 | 1186 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3416 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2006 | 2639 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 3322 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 3358 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2004 | 2568 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4481 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15936 | 0.000 |
Why?
|
Concepts
(337)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_